Are you wondering about others' experiences with Inrebic (fedratinib) for myeloproliferative neoplasms?
Inrebic is a JAK inhibitor that received FDA approval in 2019. It's used to treat three forms of myelofibrosis:
- High-risk myelofibrosis
- Post-polycythemia vera myelofibrosis
- Post-essential thrombocythemia Show Full Answer
Are you wondering about others' experiences with Inrebic (fedratinib) for myeloproliferative neoplasms?
Inrebic is a JAK inhibitor that received FDA approval in 2019. It's used to treat three forms of myelofibrosis:
- High-risk myelofibrosis
- Post-polycythemia vera myelofibrosis
- Post-essential thrombocythemia myelofibrosis with an enlarged spleen It's worth knowing some potential side effects to watch for while on Inrebic. Always discuss these with your care team:
- Nausea and digestive issues
- Fatigue
- Diarrhea
- Swelling in the legs or feet
As with any MPN treatment, regular monitoring with your hematologist is really important to make sure it's working well for you. Sharing your experience or questions with others on myMPNteam who may also be taking Inrebic can be a great way to learn how others are managing.
April 30
Join
Your Privacy Choices
